Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kayvan Keshari"'
Autor:
Angela Maria Savino, Briana Turner, Sangmoo Jeong, Tanya Schild, Xuejing Yang, Hanzhi Luo, Rachel Chirayil, Quinlan Cullen, Mandy Chan, Grace Han, Kathryn Chang, Sudha Janaki Raman, Justin R Cross, Kayvan Keshari, Michael G Kharas
Publikováno v:
Blood. 140:2966-2967
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77e43a7dd9a9a2c49c92841e75b04b37
https://doi.org/10.1182/blood-2022-164626
https://doi.org/10.1182/blood-2022-164626
Autor:
Robert, Bok, Jessie, Lee, Renuka, Sriram, Kayvan, Keshari, Subramaniam, Sukumar, Saeed, Daneshmandi, David E, Korenchan, Robert R, Flavell, Daniel B, Vigneron, John, Kurhanewicz, Pankaj, Seth
Publikováno v:
Cancers
This study applied a dual-agent, 13C-pyruvate and 13C-urea, hyperpolarized 13C magnetic resonance spectroscopic imaging (MRSI) and multi-parametric (mp) 1H magnetic resonance imaging (MRI) approach in the transgenic adenocarcinoma of mouse prostate (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ce8ef8ea90c690fce90eeca010b13520
https://pubmed.ncbi.nlm.nih.gov/30813322
https://pubmed.ncbi.nlm.nih.gov/30813322
Autor:
Brian J, Dewar, Kayvan, Keshari, Rex, Jeffries, Petras, Dzeja, Lee M, Graves, Jeffrey M, Macdonald
Publikováno v:
Metabolomics
The goal of this study was to examine metabolic differences between a novel chronic myelogenous leukemic (CML) cell line, MyL, and a sub-clone, MyL-R, which displays enhanced resistance to the targeted Bcr-Abl tyrosine kinase inhibitor imatinib. (1)H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::efba7c43f657ed8d58c327138d8c63e9
https://pubmed.ncbi.nlm.nih.gov/20676217
https://pubmed.ncbi.nlm.nih.gov/20676217